Works matching AU van der Vijgh, W. J. F.

Results: 18

The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB.

Published in:

2011

By:

Jacobs, H.;
Bast, A.;
Peters, G. J.;
van der Vijgh, W. J. F.;
Haenen, G. R. M. M.

Publication type:

journal article

The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study.

Published in:

2007

By:

Bruynzeel, A. M. E.;
Niessen, H. W. M.;
Bronzwaer, J. G. F.;
van der Hoeven, J. J. M.;
Berkhof, J.;
Bast, A.;
van der Vijgh, W. J. F.;
van Groeningen, C. J.

Publication type:

journal article

Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice.

Published in:

2007

By:

Bruynzeel, A. M. E.;
Abou El Hassan, M. A.;
Schalkwijk, C.;
Berkhof, J.;
Bast, A.;
Niessen, H. W. M.;
van der Vijgh, W. J. F.

Publication type:

journal article

Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells.

Published in:

2007

By:

Bruynzeel, A. M. E.;
Abou El Hassan, M. A.;
Torun, E.;
Bast, A.;
van der Vijgh, W. J. F.;
Kruyt, F. A. E.

Publication type:

journal article

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.

Published in:

British Journal of Cancer, 2005, v. 92, n. 9, p. 1636, doi. 10.1038/sj.bjc.6602553

By:

Boven, E.;
Westerman, M.;
van Groeningen, C. J.;
Verschraagen, M.;
Ruijter, R.;
Zegers, I.;
van der Vijgh, W. J. F.;
Giaccone, G.

Publication type:

Article

Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.

Published in:

British Journal of Cancer, 2004, v. 90, n. 8, p. 1654, doi. 10.1038/sj.bjc.6601719

By:

Verschraagen, M.;
Boven, E.;
Torun, E.;
Erkelens, C. A. M.;
Hausheer, F. H.;
van der Vijgh, W. J. F.

Publication type:

Article

A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.

Published in:

2003

By:

Abou-El-Hassan, M A I;
Rabelink, M J W E;
van der Vijgh, W J F;
Bast, A;
Hoeben, R C

Publication type:

journal article

The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro.

Published in:

2003

By:

Abou El Hassan, M A I;
Verheul, H M W;
Jorna, A S;
Schalkwijk, C;
van Bezu, J;
van der Vijgh, W J F;
Bast, A

Publication type:

journal article

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.

Published in:

British Journal of Cancer, 1999, v. 80, n. 7, p. 981, doi. 10.1038/sj.bjc.6690452

By:

Moorsel, C J A van;
Pinedo, H M;
Veerman, G;
Bergman, A M;
Kuiper, C M;
Vermorken, J B;
van der Vijgh, W J F;
Peters, G J

Publication type:

Article

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.

Published in:

British Journal of Cancer, 1999, v. 79, n. 1, p. 82, doi. 10.1038/sj.bjc.6690015

By:

Welters, M J P;
Fichtinger-Schepman, A M J;
Baan, R A;
Jacobs-Bergmans, A J;
Kegel, A;
van der Vijgh, W J F;
Braakhuis, B J M

Publication type:

Article

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 509, doi. 10.1007/s00280-006-0191-z

By:

Kroep, J. R.;
Smit, E. F.;
Giaccone, G.;
van der Born, K.;
Beijnen, J. H.;
van Groeningen, C. J.;
van der Vijgh, W. J. F.;
Postmus, P. E.;
Pinedo, H. M.;
Peters, G. J.

Publication type:

Article

Protectors against doxorubicin-induced cardiotoxicity: Flavonoids.

Published in:

Cell Biology & Toxicology, 2007, v. 23, n. 1, p. 39, doi. 10.1007/s10565-006-0139-4

By:

Bast, A.;
Kaiserová, H.;
den Hartog, G. J. M.;
Haenen, G. R. M. M.;
van der Vijgh, W. J. F.

Publication type:

Article

Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG.

Published in:

British Journal of Clinical Pharmacology, 2007, v. 63, n. 4, p. 505, doi. 10.1111/j.1365-2125.2007.02886_4.x

By:

Joerger, M.;
Huitema, A. D. R.;
Richel, D. J.;
Dittrich, C.;
Pavlidis, N.;
Briasoulis, E.;
Vermorken, J. B.;
Strocchi, E.;
Martoni, A.;
Sorio, R.;
Sleeboom, H. P.;
Izquierdo, M. A.;
Jodrell, D. I.;
Calvert, A. H.;
Boddy, A.;
Hollema, H.;
Féty, R.;
Van der Vijgh, W. J. F.;
Hempel, G.;
Chatelut, E.

Publication type:

Article

Intestinal absorption of strontium chloride in healthy volunteers: pharmacokinetics and reproducibility.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 6, p. 543, doi. 10.1046/j.1365-2125.1996.33411.x

By:

SIPS, A. J. A. M.;
Van Der VIJGH, W. J. F.;
BARTO, R.;
NETELENBOS, J. C.

Publication type:

Article

Human Pharmacokinetics of Orally Administered (24 A)-Hydroxycalcidiol.

Published in:

Clinical Chemistry & Laboratory Medicine, 1993, v. 31, n. 7, p. 419

By:

Leeuwenkamp, O. R.;
van der Wiel, H. E.;
Lips, P.;
van der Vijgh, W. J. F.;
Barto, R.;
Greuter, H.;
Netelenbos, J. C.

Publication type:

Article

Improvements in the Simultaneous Determination of Calcidiol and Calcitriol in Human Serum or Plasma.

Published in:

Clinical Chemistry & Laboratory Medicine, 1988, v. 26, n. 1, p. 25

By:

Jongen, M. J.;
Kuiper, S.;
van der Vijgh, W. J. F.;
Lips, P.;
Netelenbos, J. C.

Publication type:

Article

Interlaboratory Variation of Vitamin D Metabolite Measurements.

Published in:

Clinical Chemistry & Laboratory Medicine, 1982, v. 20, n. 10, p. 753

By:

Jongen, M. J. M.;
Van der Vijgh, W. J. F.;
Van Beresteyn, E. C. H.;
Van den Berg, H.;
Bosch, R.;
Hoogenboezem, T.;
Visser, T. J.;
Netelenbos, J. C.

Publication type:

Article

The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.

Published in:

Cancer Gene Therapy, 2003, v. 10, n. 4, p. 270, doi. 10.1038/sj.cgt.7700564

By:

Abou El Hassan, M A I;
Heijn, M;
Rabelink, M J W E;
van der Vijgh, W J F;
Bast, A;
Hoeben, R C

Publication type:

Article